CA125 response to bevacizumab in recurrent ovarian cancer.

被引：1
|
作者：
O'Cearbhaill, R. E. [1 ]
Zhou, Q. [1 ]
Iasonos, A. [1 ]
Diaz, J. P. [1 ]
Tew, W. P. [1 ]
Hensley, M. L. [1 ]
O'Flaherty, C. [1 ]
Aghajanian, C. [1 ]
Spriggs, D. R. [1 ]
Sabbatini, P. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5077
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] CA125 in ovarian cancer
    Scholler, Nathalie
    Urban, Nicole
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 513 - 523
  • [2] Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer
    Schorge, JO
    Drake, RD
    Lee, H
    Skates, SJ
    Rajanbabu, R
    Miller, DS
    Kim, JH
    Cramer, DW
    Berkowitz, RS
    Mok, SC
    CLINICAL CANCER RESEARCH, 2004, 10 (10) : 3474 - 3478
  • [3] CA125 based diagnosis and therapy in recurrent ovarian cancer
    Meier, W
    Baumgartner, L
    Stieber, P
    Hasholzner, U
    FatehMoghadam, A
    ANTICANCER RESEARCH, 1997, 17 (4B) : 3019 - 3020
  • [4] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
  • [5] CA125 response: Can it replace the traditional response criteria in ovarian cancer?
    Guppy, AE
    Rustin, GJS
    ONCOLOGIST, 2002, 7 (05): : 437 - 443
  • [6] Prechemotherapy serum CA125 level, CA125 kinetics and its half-life as prognostic factors in advanced ovarian cancer.
    Colakovic, S
    Lukic, V
    Mitrovic, L
    Jelic, S
    Susnjar, S
    Marinkovic, J
    ANNALS OF ONCOLOGY, 2000, 11 : 82 - 83
  • [7] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [8] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339
  • [9] Tumor marker CA125 in ovarian cancer
    Tuxen, MK
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2001, 16 (01): : 49 - 68
  • [10] CA125 and Ovarian Cancer: A Comprehensive Review
    Charkhchi, Parsa
    Cybulski, Cezary
    Gronwald, Jacek
    Wong, Fabian Oliver
    Narod, Steven A.
    Akbari, Mohammad R.
    CANCERS, 2020, 12 (12) : 1 - 29
12345